COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,220 Articles (22,733 medRxiv, 8,487 bioRxiv)

Most recent first Previous |  Page 1236: Articles 12351-12360  | Next

Hospital-level work organization drives the spread of SARS-CoV-2 within hospitals: insights from a multi-ward model
Oodally, A., Hammami, P., Reilhac, A., Guerineau de Lamerie, G., Opatowski, L., Temime, L.
10.1101/2021.09.09.21262609 — Posted: 2021-09-17
Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study
Swann, S. V., Pollock, L., Holden, K. A., Munro, A. P., Bennett, A., Williams, T. C., Turtle, L., Fairfield, C. J., Drake, T. M., Faust, S. N., Sinha, I. P., Roland, D., Whittaker, E., Ladhani, S., Nguyen-Van-Tam, J. S., Girvan, M., Donohue, C., Donegan, C., Spencer, R. G., Hardwick, H. E., Openshaw, P. J., Baillie, J. K., Harrison, E. M., Docherty, A. B., Semple, M. G., ISARIC4C Investigators
10.1101/2021.09.14.21263567 — Posted: 2021-09-17
COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April- August 2021
de Gier, B., Kooijman, M., Kemmeren, J., de Keizer, N., Dongelmans, D., van Iersel, S. C. J. L., van de Kassteele, J., Andeweg, S. P., the RIVM COVID-19 epidemiology and surveillance team, , de Melker, H. E., Hahne, S. J. M., Knol, M. J., van den Hof, S.
10.1101/2021.09.15.21263613 — Posted: 2021-09-17 Discussion: Offsite
Predominance of Distinct Autoantibodies in Response to SARS-CoV-2 Infection
Liu, Y., Ebinger, J. E., Mostafa, R., Budde, P., Gajewski, J., Walker, B., Joung, S., Bräutigam, M., Hesping, F., Schäefer, E., Schubert, A.-S., Zucht, H.-D., Melmed, G. Y., Sobhani, K., Braun, J., McGovern, D. P. B., Van Eyk, J. E., Cheng, S., Fert-Bober, J.
10.1101/2021.09.14.21263603 — Posted: 2021-09-17
Widening Disparities in Online Information Access during the COVID-19 Pandemic
Suh, J., Horvitz, E., White, R. W., Althoff, T.
10.1101/2021.09.14.21263545 — Posted: 2021-09-17
Dysregulated immune responses in COVID-19 patients correlating with disease severity and invasive oxygen requirements
Garcia-Gonzalez, P., Tempio, F., Fuentes, C., Merino, C., Vargas, L., Simon, V., Ramirez, M., Rojas, V., Tobar, E., Landskron, G., Araya, J. P., Navarrete, M., Bastias, C., Tordecilla, R., Varas, M., Maturana, P., Marcoleta, A., Allende, M., Naves, R., Hermoso, M., Salazar-Onfray, F., Lopez, M., Bono, M. R., Osorio, F.
10.1101/2021.09.14.21263541 — Posted: 2021-09-17
Geographic and Phylodynamic Distribution of SARS-CoV-2 from Environmental Origin
Oladipo, E. K., Irewolede, B. A., Oyewole, P. M., Dairo, E. O., Ayeni, A. E., Adetunji, C. O., Oloke, J. K.
10.1101/2021.09.13.21263432 — Posted: 2021-09-16
Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein
Castro, J., Fumagalli, M., Hojo-Souza, N., Azevedo, P., Salazar, N., Rattis, B., Ramos, S., Faustino, L., Almeida, G., Oliveira, L., Marcal, T., Augusto, M., Magalhaes, R. D. M., Cassaro, B., Burle, G., Doro, D., Kalil, J., Durigon, E. L., Salazar, A., Caballero, O., Machado, A., da Silva, J., da Fonseca, F., Fernandes, A. P., Teixeira, S., Gazzinelli, R.
10.1101/2021.09.16.460663 — Posted: 2021-09-16
Signatures of adaptive evolution during human to mink SARS CoV2 cross species transmission inform estimates of the COVID19 pandemic timing
Tai, J.-H., Chaw, S.-M., Sun, H.-Y., Tseng, Y.-C., Li, G., Chang, S.-Y., Yeh, S.-H., Chen, P.-J., Wang, H.-Y.
10.1101/2021.09.15.459215 — Posted: 2021-09-16
Humoral immune responses against seasonal coronaviruses predict efficiency of SARS-CoV-2 spike targeting, FcγR activation, and corresponding COVID-19 disease severity
Garrido, J. J., Medina, M., Bravo, F., McGee, S., Fuentes, F., Calvo, M., Bowman, J. W., Bahl, C. D., Barria, M. I., Brachman, R. A., Alvarez, R. A.
10.1101/2021.09.14.460338 — Posted: 2021-09-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).